These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29067649)

  • 1. Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development.
    Shi Q; Chen YG
    Sci China Life Sci; 2017 Oct; 60(10):1133-1141. PubMed ID: 29067649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
    Park JS; Choi HI; Kim DH; Kim CS; Bae EH; Ma SK; Kim SW
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
    Hao Y; Baker D; Ten Dijke P
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal Growth Factor Receptor and Transforming Growth Factor β Signaling Pathways Cooperate To Mediate
    Igietseme JU; Partin J; George Z; Omosun Y; Goldstein J; Joseph K; Ellerson D; Eko FO; Pohl J; Bandea C; Black CM
    Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31964750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells.
    Biver E; Thouverey C; Magne D; Caverzasio J
    Mol Cell Endocrinol; 2014 Jan; 382(1):120-130. PubMed ID: 24060635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
    Ahmadi A; Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-Derived Growth Factor Receptor Activation Promotes the Prodestructive Invadosome-Forming Phenotype of Synoviocytes from Patients with Rheumatoid Arthritis.
    Charbonneau M; Lavoie RR; Lauzier A; Harper K; McDonald PP; Dubois CM
    J Immunol; 2016 Apr; 196(8):3264-75. PubMed ID: 26976956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.
    Verrecchia F; Mauviel A
    J Invest Dermatol; 2002 Feb; 118(2):211-5. PubMed ID: 11841535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
    Matalkah F; Martin E; Zhao H; Agazie YM
    Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichotomous roles of TGF-β in human cancer.
    Huang JJ; Blobe GC
    Biochem Soc Trans; 2016 Oct; 44(5):1441-1454. PubMed ID: 27911726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
    PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.
    Liu X; Yun F; Shi L; Li ZH; Luo NR; Jia YF
    Asian Pac J Cancer Prev; 2015; 16(15):6201-6. PubMed ID: 26434817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.